369 related articles for article (PubMed ID: 28032521)
1. The influence of direct compression powder blend transfer method from the container to the tablet press on product critical quality attributes: a case study.
Teżyk M; Jakubowska E; Milczewska K; Milanowski B; Voelkel A; Lulek J
Drug Dev Ind Pharm; 2017 Jun; 43(6):911-916. PubMed ID: 28032521
[TBL] [Abstract][Full Text] [Related]
2. A quality-by-design study for an immediate-release tablet platform: examining the relative impact of active pharmaceutical ingredient properties, processing methods, and excipient variability on drug product quality attributes.
Kushner J; Langdon BA; Hicks I; Song D; Li F; Kathiria L; Kane A; Ranade G; Agarwal K
J Pharm Sci; 2014 Feb; 103(2):527-38. PubMed ID: 24375069
[TBL] [Abstract][Full Text] [Related]
3. Particle Engineering for Enabling a Formulation Platform Suitable for Manufacturing Low-Dose Tablets by Direct Compression.
Sun WJ; Aburub A; Sun CC
J Pharm Sci; 2017 Jul; 106(7):1772-1777. PubMed ID: 28322940
[TBL] [Abstract][Full Text] [Related]
4. Analytical method development for powder characterization: Visualization of the critical drug loading affecting the processability of a formulation for direct compression.
Hirschberg C; Sun CC; Rantanen J
J Pharm Biomed Anal; 2016 Sep; 128():462-468. PubMed ID: 27368089
[TBL] [Abstract][Full Text] [Related]
5. How do formulation and process parameters impact blend and unit dose uniformity? Further analysis of the product quality research institute blend uniformity working group industry survey.
Hancock BC; Garcia-Munoz S
J Pharm Sci; 2013 Mar; 102(3):982-6. PubMed ID: 23280670
[TBL] [Abstract][Full Text] [Related]
6. An investigation into the effects of excipient particle size, blending techniques and processing parameters on the homogeneity and content uniformity of a blend containing low-dose model drug.
Alyami H; Dahmash E; Bowen J; Mohammed AR
PLoS One; 2017; 12(6):e0178772. PubMed ID: 28609454
[TBL] [Abstract][Full Text] [Related]
7. Reduction of tablet weight variability by optimizing paddle speed in the forced feeder of a high-speed rotary tablet press.
Peeters E; De Beer T; Vervaet C; Remon JP
Drug Dev Ind Pharm; 2015 Apr; 41(4):530-9. PubMed ID: 24502268
[TBL] [Abstract][Full Text] [Related]
8. Blend Segregation in Tablets Manufacturing and Its Effect on Drug Content Uniformity-A Review.
Jakubowska E; Ciepluch N
Pharmaceutics; 2021 Nov; 13(11):. PubMed ID: 34834324
[TBL] [Abstract][Full Text] [Related]
9. Effect of drug proportion and mixing time on the content uniformity of a low dose drug in a high shear mixer.
Kornchankul W; Hamed E; Parikh NH; Sakr A
Pharmazie; 2002 Jan; 57(1):49-53. PubMed ID: 11836931
[TBL] [Abstract][Full Text] [Related]
10. Streamlining of the Powder Mixing Process based on a Segregation Test.
Römerová S; Dammer O; Zámostný P
AAPS PharmSciTech; 2021 Jun; 22(5):190. PubMed ID: 34159445
[TBL] [Abstract][Full Text] [Related]
11. Provoking an end-to-end continuous direct compression line with raw materials prone to segregation.
Lakio S; Ervasti T; Tajarobi P; Wikström H; Fransson M; Karttunen AP; Ketolainen J; Folestad S; Abrahmsén-Alami S; Korhonen O
Eur J Pharm Sci; 2017 Nov; 109():514-524. PubMed ID: 28899763
[TBL] [Abstract][Full Text] [Related]
12. Crystal and Particle Engineering Strategies for Improving Powder Compression and Flow Properties to Enable Continuous Tablet Manufacturing by Direct Compression.
Chattoraj S; Sun CC
J Pharm Sci; 2018 Apr; 107(4):968-974. PubMed ID: 29247737
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the powder behavior and the residence time distribution within a production scale rotary tablet press.
Dülle M; Özcoban H; Leopold CS
Eur J Pharm Sci; 2018 Dec; 125():205-214. PubMed ID: 30312745
[TBL] [Abstract][Full Text] [Related]
14. In-line monitoring of the drug content of powder mixtures and tablets by near-infrared spectroscopy during the continuous direct compression tableting process.
Järvinen K; Hoehe W; Järvinen M; Poutiainen S; Juuti M; Borchert S
Eur J Pharm Sci; 2013 Mar; 48(4-5):680-8. PubMed ID: 23313622
[TBL] [Abstract][Full Text] [Related]
15. Improved properties of fine active pharmaceutical ingredient powder blends and tablets at high drug loading via dry particle coating.
Kunnath K; Huang Z; Chen L; Zheng K; Davé R
Int J Pharm; 2018 May; 543(1-2):288-299. PubMed ID: 29625168
[TBL] [Abstract][Full Text] [Related]
16. Real-time monitoring of pharmaceutical properties of medical tablets during direct tableting process by hybrid tableting process parameter-time profiles.
Saito S; Hattori Y; Sakamoto T; Otsuka M
Biomed Mater Eng; 2020; 30(5-6):509-524. PubMed ID: 31771033
[TBL] [Abstract][Full Text] [Related]
17. On-Demand Manufacturing of Direct Compressible Tablets: Can Formulation Be Simplified?
Azad MA; Osorio JG; Wang A; Klee DM; Eccles ME; Grela E; Sloan R; Hammersmith G; Rapp K; Brancazio D; Myerson AS
Pharm Res; 2019 Oct; 36(12):167. PubMed ID: 31650274
[TBL] [Abstract][Full Text] [Related]
18. Segregation of formulated powders in direct compression process and evaluations by small bench-scale testers.
Deng T; Sousa LM; Garg V; Bradley MSA
Int J Pharm; 2023 Nov; 647():123544. PubMed ID: 37871870
[TBL] [Abstract][Full Text] [Related]
19. Integrating sensors for monitoring blend content in a pharmaceutical continuous manufacturing plant.
Panikar S; Li J; Rane V; Gillam S; Callegari G; Kurtyka B; Lee S; Muzzio F
Int J Pharm; 2021 Sep; 606():120085. PubMed ID: 33737095
[TBL] [Abstract][Full Text] [Related]
20. Formulation of Direct Compression Zidovudine Tablets to Correlate the SeDeM Diagram Expert System and the Rotary Press Simulator Styl'ONE Results.
Nofrerias I; Nardi A; Suñé-Pou M; Suñé-Negre JM; García-Montoya E; Pérez-Lozano P; Miñarro M; Bataille B; Ticó JR
AAPS PharmSciTech; 2019 Nov; 21(1):1. PubMed ID: 31712905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
